BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families

Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer. BRCA1/2 testing: uptake, phenocop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fischer, Christine (VerfasserIn) , Sutter, Christian (VerfasserIn) , Voigtländer, Theda (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: Clinical genetics
Year: 2011, Jahrgang: 82, Heft: 5, Pages: 478-483
ISSN:1399-0004
DOI:10.1111/j.1399-0004.2011.01788.x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/j.1399-0004.2011.01788.x
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0004.2011.01788.x
Volltext
Verfasserangaben:Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer

MARC

LEADER 00000caa a2200000 c 4500
001 1581491042
003 DE-627
005 20220815023122.0
007 cr uuu---uuuuu
008 181002r20122011xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1399-0004.2011.01788.x  |2 doi 
035 |a (DE-627)1581491042 
035 |a (DE-576)511491042 
035 |a (DE-599)BSZ511491042 
035 |a (OCoLC)1341019538 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fischer, Christine  |d 1955-  |e VerfasserIn  |0 (DE-588)128461993  |0 (DE-627)373010362  |0 (DE-576)297159674  |4 aut 
245 1 0 |a BRCA1/2 testing  |b uptake, phenocopies, and strategies to improve detection rates in initially negative families  |c Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer 
264 1 |c 2012 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: 15 September 2011 
500 |a Gesehen am 02.11.2018 
520 |a Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer. BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families. In families with clustering of breast and ovarian cancer, molecular testing of the major susceptibility genes BRCA1/2 helps to identify patients with disease mutations and healthy persons at high risk who can participate in targeted intervention programs. We investigated 5559 families from the German Consortium for Hereditary Breast and Ovarian Cancer included between 1997 and 2008 and treated under clinical routine conditions. In each family an index patient/person had been screened for deleterious mutations in BRCA1/2. Healthy relatives agreed to predictive testing in 888 of 1520 BRCA1/2 mutation-positive families (58%). Of 2646 eligible unaffected first-degree relatives 1143 decided to be tested (43%). In 325 families with BRCA1/2-positive index patients one related BC/OC patient was tested and 39 (12.0%; 95% confidence interval: 8.7-16.0%) discrepant cases found. A second related individual was screened in 163 of 3388 (4.9%) families with BRCA1/2-negative index patient and in eight families a BRCA1/2 mutation was found. In BRCA1/2 mutation-positive families, BC/OC patients lacking the familial mutation have to be expected at a rather high rate. In families with BRCA1/2-negative index patient we recommend a second screening if another patient with a high probability of carrying a BRCA1/2 mutation is available. 
534 |c 2011 
650 4 |a BRCA1/2 testing 
650 4 |a discrepant results 
650 4 |a phenocopies 
650 4 |a second mutational screening 
650 4 |a true negatives 
650 4 |a uptake of genetic testing 
700 1 |a Sutter, Christian  |e VerfasserIn  |0 (DE-588)1067529160  |0 (DE-627)818862068  |0 (DE-576)42671993X  |4 aut 
700 1 |a Voigtländer, Theda  |e VerfasserIn  |0 (DE-588)1144653312  |0 (DE-627)1004945035  |0 (DE-576)495461091  |4 aut 
773 0 8 |i Enthalten in  |t Clinical genetics  |d Oxford : Wiley-Blackwell, 1970  |g 82(2012), 5, Seite 478-483  |h Online-Ressource  |w (DE-627)320437949  |w (DE-600)2004581-5  |w (DE-576)091142628  |x 1399-0004  |7 nnas  |a BRCA1/2 testing uptake, phenocopies, and strategies to improve detection rates in initially negative families 
773 1 8 |g volume:82  |g year:2012  |g number:5  |g pages:478-483  |g extent:6  |a BRCA1/2 testing uptake, phenocopies, and strategies to improve detection rates in initially negative families 
856 4 0 |u http://dx.doi.org/10.1111/j.1399-0004.2011.01788.x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0004.2011.01788.x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181002 
993 |a Article 
994 |a 2012 
998 |g 1144653312  |a Voigtländer, Theda  |m 1144653312:Voigtländer, Theda  |d 910000  |d 911500  |e 910000PV1144653312  |e 911500PV1144653312  |k 0/910000/  |k 1/910000/911500/  |p 17  |y j 
998 |g 1067529160  |a Sutter, Christian  |m 1067529160:Sutter, Christian  |d 910000  |d 911500  |e 910000PS1067529160  |e 911500PS1067529160  |k 0/910000/  |k 1/910000/911500/  |p 3 
998 |g 128461993  |a Fischer, Christine  |m 128461993:Fischer, Christine  |d 910000  |d 911500  |e 910000PF128461993  |e 911500PF128461993  |k 0/910000/  |k 1/910000/911500/  |p 1  |x j 
999 |a KXP-PPN1581491042  |e 302757860X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"uptake, phenocopies, and strategies to improve detection rates in initially negative families","title":"BRCA1/2 testing","title_sort":"BRCA1/2 testing"}],"name":{"displayForm":["Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"6 S."}],"recId":"1581491042","language":["eng"],"note":["First published: 15 September 2011","Gesehen am 02.11.2018"],"person":[{"display":"Fischer, Christine","role":"aut","roleDisplay":"VerfasserIn","family":"Fischer","given":"Christine"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Sutter, Christian","family":"Sutter","given":"Christian"},{"given":"Theda","family":"Voigtländer","roleDisplay":"VerfasserIn","role":"aut","display":"Voigtländer, Theda"}],"id":{"doi":["10.1111/j.1399-0004.2011.01788.x"],"eki":["1581491042"]},"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"relHost":[{"title":[{"title":"Clinical genetics","title_sort":"Clinical genetics"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1970 -"],"disp":"BRCA1/2 testing uptake, phenocopies, and strategies to improve detection rates in initially negative familiesClinical genetics","physDesc":[{"extent":"Online-Ressource"}],"recId":"320437949","language":["eng"],"note":["Gesehen am 19.05.08"],"id":{"eki":["320437949"],"issn":["1399-0004"],"zdb":["2004581-5"],"doi":["10.1111/(ISSN)1399-0004"]},"origin":[{"dateIssuedKey":"1970","publisher":"Wiley-Blackwell ; Wiley ; Munksgaard ; Blackwell","publisherPlace":"Oxford ; Malden, Mass. ; Copenhagen ; Oxford [u.a.]","dateIssuedDisp":"1970-"}],"part":{"text":"82(2012), 5, Seite 478-483","issue":"5","volume":"82","pages":"478-483","year":"2012","extent":"6"}}]} 
SRT |a FISCHERCHRBRCA12TEST2012